Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

标题
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
作者
关键词
Lipid-lowering drugs, Clinical trials, PCSK9, Lipoproteins, Monoclonal antibodies
出版物
Journal of Clinical Lipidology
Volume 9, Issue 6, Pages 758-769
出版商
Elsevier BV
发表日期
2015-08-29
DOI
10.1016/j.jacl.2015.08.006

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started